Most recent articles by:

Markus Veit

https://www.alphatopics.de/

- Advertisement -

Comment

The Maze Of Regulatory Requirements For Cannabis Medicinal Products In Europe – An Impression Of Scattered Regionalism, Associated With Risks For Patients

By Prof. Dr. Markus Veit, Managing Director, Alphatopics GmbH IN the absence of existing national or European requirements, the regionally competent authorities in our...

Markus Veit - January 10, 2023

Must read

Medicinal CannabisFebruary 8, 2023

Norway Hosts First Public Meeting On Medical Cannabis Amid ‘Early First Steps’ Towards Potential Reform

NORWAY, one of the most cautious states in Europe...

CBDFebruary 7, 2023

Love Hemp ‘Rigorously Refutes’ Allegations Of Fraud Levelled By Former Managing Director

LOVE Hemp has responded to damning allegations made publicly...

- Advertisement -

Markus Veit

Must read

Norway Hosts First Public Meeting On Medical Cannabis Amid ‘Early First Steps’ Towards Potential Reform

Love Hemp ‘Rigorously Refutes’ Allegations Of Fraud Levelled By Former Managing Director

Editor Picks

Huge Stride For UK Medicinal Cannabis With £12m Plan To Cultivate 300,000 Plants A Year

Amazon Enters CBD Retail Market – But Only In One Country

New ‘Cannabis Initiative’ From ‘Secretive’ UN Body May Cause Serious Harm To Global Industry

Must Read

Can CBD Be Sold As ‘Hemp Oil’ To Avoid Novel Food Rules?

Legal UK Cannabis Industry Mapped Out For First Time – And Poised For Rapid Change

Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

BusinessCann

About BusinessCann

Follow Us